unknown
Stage
About
4SC AG is a Germany-based biopharmaceutical company that discovers and develops small-molecule therapeutics, primarily for oncology. The company focuses on targeted kinase and epigenetic inhibitors and advances candidates through clinical development.
Explore 4SC AG's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.